stock valueI think that we need to focus on the fundamentals of onc. What is happening with syb is largely irrelevant. For whatever reason the market is valuing onc at its current level because of the lack of more info as to efficacy. Once further info is released by onc in this regard then the stock price will react accordingly. I think the selling that has been going on is simply profit taking during the run up to the latest news release.
I think that it is easy to lose perspective when thinking about extraneous factors such as syb.
Ultimately onc will be given a market value that reflects its long term value, whether that is higher or lower.
The news to date exited me and I thought that the price would be considerably higher than it currently is however I think that the market is valuing this company on a more objective basis.
It is still early in the game.